IFNA1 and systemic lupus erythematosus: Then, the IFN signaling can promote the autocrine activation of DCs and their capacity to stimulate T-cells (40), allowing the subsequent release of (pathogenic) exosomes that could reach and activate immune cells at remote sites via blood circulation, thus boosting a vicious circle of immune stimulation in SLE.